Cover Image
市場調查報告書

Active Biotech AB的產品平台分析

Active Biotech AB - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 192433
出版日期 內容資訊 英文 33 Pages
訂單完成後即時交付
價格
Back to Top
Active Biotech AB的產品平台分析 Active Biotech AB - Product Pipeline Review - 2014
出版日期: 2014年05月30日 內容資訊: 英文 33 Pages
簡介

Active Biotech AB這個生物科技企業主要致力於自體免疫/發炎性疾病,癌症治療藥的研究及商品化。

本報告提供Active Biotech AB上的治療藥開發平台現狀及各開發階段比較分析,提供藥物標的,作用機制,給藥途徑,各類型分子的治療藥評估,以及最新的企業新聞和發表,後期階段及中止計劃的相關資訊等。

Active Biotech AB的基本資料

Active Biotech AB概要

  • 主要資訊
  • 企業資料

Active Biotech AB:R&D概要

  • 主要的治療範圍

Active Biotech AB:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Active Biotech AB:開發中產品概況

  • 位於最終階段的開發中產品
    • 位於第三階段的產品/聯合治療模式
  • 位於臨床實驗階段的開發中產品
    • 位於第二階段的產品/聯合治療模式
  • 位於初期階段的開發中產品
    • 位於前臨床階段的產品/聯合治療模式

Active Biotech AB:藥物簡介

  • tasquinimod
  • naptumomab estafenatox
  • paquinimod
  • ISI

Active Biotech AB:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各類型分子
  • 各作用機制

Active Biotech AB:最近的開發平台趨勢

Active Biotech AB:暫停中的計劃

Active Biotech AB:中止開發的開發中產品

  • 中止開發的開發中產品簡介
  • ABR-224050

Active Biotech AB:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC04892CDB

Global Markets Direct's, 'Active Biotech AB - Product Pipeline Review - 2014', provides an overview of the Active Biotech AB's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Active Biotech AB's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Active Biotech AB including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Active Biotech AB's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Active Biotech AB's pipeline products

Reasons to buy

  • Evaluate Active Biotech AB's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Active Biotech AB in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Active Biotech AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Active Biotech AB and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Active Biotech AB
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Active Biotech AB and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Active Biotech AB Snapshot
    • Active Biotech AB Overview
    • Key Information
    • Key Facts
  • Active Biotech AB - Research and Development Overview
    • Key Therapeutic Areas
  • Active Biotech AB - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Active Biotech AB - Pipeline Products Glance
    • Active Biotech AB - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Active Biotech AB - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Active Biotech AB - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Active Biotech AB - Drug Profiles
    • tasquinimod
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • naptumomab estafenatox
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • paquinimod
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ISI
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Active Biotech AB - Pipeline Analysis
    • Active Biotech AB - Pipeline Products by Target
    • Active Biotech AB - Pipeline Products by Route of Administration
    • Active Biotech AB - Pipeline Products by Molecule Type
    • Active Biotech AB - Pipeline Products by Mechanism of Action
  • Active Biotech AB - Recent Pipeline Updates
  • Active Biotech AB - Dormant Projects
  • Active Biotech AB - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • ABR-224050
  • Active Biotech AB - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Active Biotech AB, Key Information
  • Active Biotech AB, Key Facts
  • Active Biotech AB - Pipeline by Indication, 2014
  • Active Biotech AB - Pipeline by Stage of Development, 2014
  • Active Biotech AB - Monotherapy Products in Pipeline, 2014
  • Active Biotech AB - Out-Licensed Products in Pipeline, 2014
  • Active Biotech AB - Out-Licensed Products/ Combination Treatment Modalities, 2014
  • Active Biotech AB - Phase III, 2014
  • Active Biotech AB - Phase II, 2014
  • Active Biotech AB - Preclinical, 2014
  • Active Biotech AB - Pipeline by Target, 2014
  • Active Biotech AB - Pipeline by Route of Administration, 2014
  • Active Biotech AB - Pipeline by Molecule Type, 2014
  • Active Biotech AB - Pipeline Products by Mechanism of Action, 2014
  • Active Biotech AB - Recent Pipeline Updates, 2014
  • Active Biotech AB - Dormant Developmental Projects,2014
  • Active Biotech AB - Discontinued Pipeline Products, 2014
  • Active Biotech AB, Subsidiaries

List of Figures

  • Active Biotech AB - Pipeline by Top 10 Indication, 2014
  • Active Biotech AB - Pipeline by Stage of Development, 2014
  • Active Biotech AB - Monotherapy Products in Pipeline, 2014
  • Active Biotech AB - Out-Licensed Products in Pipeline, 2014
  • Active Biotech AB - Pipeline by Top 10 Target, 2014
  • Active Biotech AB - Pipeline by Top 10 Route of Administration, 2014
  • Active Biotech AB - Pipeline by Top 10 Molecule Type, 2014
  • Active Biotech AB - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top